- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/08 - Bridged systems
Patent holdings for IPC class C07D 498/08
Total number of patents in this class: 1175
10-year publication summary
|
68
|
77
|
97
|
70
|
66
|
95
|
93
|
101
|
100
|
82
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4757 |
34 |
| Takeda Pharmaceutical Company Limited | 2698 |
34 |
| VALO Health, Inc. | 195 |
32 |
| Amgen Inc. | 4445 |
24 |
| Novartis AG | 10174 |
18 |
| Vertex Pharmaceuticals Incorporated | 1576 |
18 |
| Merck Sharp & Dohme LLC | 3734 |
18 |
| Boehringer Ingelheim International GmbH | 4488 |
17 |
| Janssen Pharmaceutica N.V. | 3150 |
17 |
| Bayer AG | 3560 |
16 |
| Bayer Pharma AG | 1009 |
16 |
| F. Hoffmann-La Roche AG | 7796 |
14 |
| Epizyme, Inc. | 360 |
13 |
| Pfizer Inc. | 3414 |
12 |
| Enanta Pharmaceuticals, Inc. | 426 |
12 |
| Voronoi Inc. | 69 |
12 |
| Merck Patent GmbH | 5742 |
11 |
| Eli Lilly and Company | 4117 |
11 |
| Taisho Pharmaceutical Co., Ltd. | 847 |
9 |
| Ctxt Pty Ltd | 62 |
9 |
| Other owners | 828 |